 | The 131st Annual Meeting (November 15-19, 2003) of APHA |
|
| The 131st Annual Meeting (November 15-19, 2003) of APHA |
Nancy A. Blume, RN, PHN, MPH1, Cheryl E. Smoot, RN, PHN, MPH2, Gwen M. Willems, BA, MA, PHD Cand3, and Kathy K. Wittnebel, RN, PHN, LSN3. (1) Child and Adolescent Health Policy, Minnesota Department of Health, 85 East Seventh Place, Suite 400, P.O. Box 64882, St. Paul, MN 55164-0882, 651-281-9939, nancy.blume@health.state.mn.us, (2) Child Health/School Health Consultant, Minnesota Department of Health, PO Box 64882, St Paul, MN 55164-0882, (3) Minnesota Department of Health, University of Minnesota, 85 East Seventh Place, Suite 400, P.O. Box 64882, St. Paul, MN 55164-0882
In 2001, the Minnesota legislature directed the Commissioner of Health to study and make recommendations promoting student health and safety in administering medications in schools. Designing a system for safe and effective medication administration in schools requires the knowledge and skills of school nurses and health care practitioners as well as the understanding and involvement of policy makers, administrators, parents, teachers and other school staff. Based on 10 principles to support safe medication administration in Minnesota schools, developed by a workgroup of key stakeholders, a state interagency staff team has begun to develop statewide standards and guidelines. Using an evidence based process informed by best practice and policy literature and research from health and education, and by the popular literature, often the information base for parents and the community, the project addresses the myriad of issues related to medications in school, the role of school staff, policy makers, families, health care providers and the community, and the policy components necessary to assure a system of safe and efficacious medication management in schools.
Participants will be able to: · Describe the policy/practice basis for the design of the standard and guideline development process. · Discuss the methodology used to conduct the literature and expert panel review. · Identify key elements from other state guidelines, nurse practice acts and interpretive statements used to inform the process. · Identify the importance of interagency and stakeholder involvement in the development of state medication guidelines
Learning Objectives:
Keywords: School Health, Policy/Policy Development
Related Web page: www.health.state.mn.us/divs/fh/mch/schoolhealth/index.html
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.